Suchergebnisse - "Specchia, Giorgina"

PubPharm (15)

1

Efficacy and safety of netupitant/palonosetron combination (NEPA) in preventing nausea and vomiting in non-Hodgkin's lymphoma patients undergoing to chemomobilization before autologous stem cell transplantation

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2022

von Di Renzo, N. | Musso, M. | Scimè, R. | +19

2

Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma : results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi

enthalten in: Annals of hematology | 2021

von Santoro, A. | Mazza, R. | Spina, M. | +24

3

Efficacy and safety of multiple doses of NEPA without dexamethasone in preventing nausea and vomiting induced by multiple-day and high-dose chemotherapy in patients with non-Hodgkin's lymphoma undergoing autologous hematopoietic stem cell transplantation : a phase IIa, multicenter study

enthalten in: Bone marrow transplantation | 2020

von Di Renzo, N. | Musso, M. | Scimè, R. | +17

4

The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design : Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting

enthalten in: Blood cancer journal | 2018

von De Stefano, V. | Rocca, B. | Tosetto, A. | +30

5

Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma : final results of a phase II study conducted by the Fondazione Italiana Linfomi

enthalten in: Haematologica | 2016

von Sacchi, S. | Marcheselli, R. | Bari, A. | +17

6

Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients

enthalten in: American journal of hematology | 2014

von Foà, R. | Del Giudice, I. | Cuneo, A. | +37

7

Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile

enthalten in: Leukemia research | 2014

von Mauro, F. | Molica, S. | Laurenti, L. | +46

8

Lenalidomide in International Prognostic Scoring System Low and Intermediate-1 risk myelodysplastic syndromes with del(5q) : an Italian phase II trial of health-related quality of life, safety and efficacy

enthalten in: Leukemia & lymphoma | 2013

von Oliva, E. | Latagliata, R. | Laganà, C. | +17

9

A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy

enthalten in: British journal of haematology | 2013

von Finazzi, G. | Vannucchi, A. | Martinelli, V. | +15

10

BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients

enthalten in: Blood | 2011

von Visani, G. | Malerba, L. | Stefani, P. | +17